Table 2 Characteristics of chemotherapy groups
| Â | Changed regimen group | Unchanged regimen group |
|---|---|---|
No. of patients | 7 | 8 |
Age | 58 (range, 25–67) | 55 (range, 44–66) |
No. of complete resection | 1 | 1 |
Preoperative chemotherapy period (months) | 23 (range, 2–49) | 16 (range, 7–52) |
No. of preoperative chemotherapy regimens (1st/2nd/3rd) | 3/3/1 | 3/3/2 |
No. of metastatic organs excluding ovarian metastases (3 organs/2 organs/1 organ/none) | 1/2/3/1 | 0/5/2/1 |
Responses of extra-ovarian metastases to pre-operative chemotherapy (CR/PR/SD/PD) | 0/0/4/3 | 0/3/5/0 |
Progression-free survival (months) | 11.0 | 10.2 |
Median survival time (months) | 18.1 | 26.2 |